Cargando…

Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC Inhibitors

The dihydropyranoindole scaffold was identified as a promising target for improving the anti-cancer activity of HDAC inhibitors from the preliminary screening of a library of compounds. A suitable methodology has been developed for the preparation of novel dihydropyranoindoles via the Hemetsberger i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bingul, Murat, Arndt, Greg M., Marshall, Glenn M., Cheung, Belamy B., Kumar, Naresh, Black, David StC.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144403/ https://www.ncbi.nlm.nih.gov/pubmed/32197360 http://dx.doi.org/10.3390/molecules25061377

Ejemplares similares

Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer Cells
por: Bingul, Murat, et al.
Publicado: (2021)

Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety
por: Bingul, Murat, et al.
Publicado: (2016)

Design, Synthesis and Biological Evaluation of Novel Anthraniloyl-AMP Mimics as PQS Biosynthesis Inhibitors Against Pseudomonas aeruginosa Resistance
por: Sabir, Shekh, et al.
Publicado: (2020)

Synthesis of Dextran–Phenoxodiol and Evaluation of Its Physical Stability and Biological Activity
por: Yee, Eugene M. H., et al.
Publicado: (2019)

Synthesis of Alkyne-Substituted Dihydropyrrolones as Bacterial Quorum-Sensing Inhibitors of Pseudomonas aeruginosa
por: Almohaywi, Basmah, et al.
Publicado: (2022)

Synthesis of Novel Quinazolinone Analogues for Quorum Sensing Inhibition
por: Shandil, Sahil, et al.
Publicado: (2023)

Synthesis of Bis-Glyoxylamide Peptidomimetics Derived from Bis-N-acetylisatins Linked at C5 by a Methylene or Oxygen Bridge
por: Suryanti, Venty, et al.
Publicado: (2019)

The anticancer effects of HDAC inhibitors require the immune system
por: West, Alison C, et al.
Publicado: (2014)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

Design, Synthesis and Biological Evaluation of Biphenylglyoxamide-Based Small Molecular Antimicrobial Peptide Mimics as Antibacterial Agents
por: Yu, Tsz Tin, et al.
Publicado: (2020)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
por: Al-Sanea, Mohammad M, et al.
Publicado: (2020)

Synthesis and Evaluation of C15 Triene Urushiol Derivatives as Potential Anticancer Agents and HDAC2 Inhibitor
por: Qi, Zhiwen, et al.
Publicado: (2018)

Design and Synthesis of Lactams Derived from Mucochloric and Mucobromic Acids as Pseudomonas aeruginosa Quorum Sensing Inhibitors
por: Almohaywi, Basmah, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of HDAC Inhibitors With a Novel Zinc Binding Group
por: He, Junquan, et al.
Publicado: (2020)

Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-One-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity
por: Khetmalis, Yogesh Mahadu, et al.
Publicado: (2023)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
por: Goehringer, Nils, et al.
Publicado: (2021)

Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
por: Dong, Hang, et al.
Publicado: (2019)

Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
por: Cross, Jasmine M., et al.
Publicado: (2020)

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
por: Jenke, Robert, et al.
Publicado: (2021)

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin–HDAC Inhibitor Hybrids as Multitarget Drugs
por: von Bredow, Lukas, et al.
Publicado: (2022)

A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner
por: Sutton, Selina K., et al.
Publicado: (2016)

Short Tryptamine-Based Peptoids as Potential Therapeutics for Microbial Keratitis: Structure-Function Correlation Studies
por: Bahatheg, Ghayah, et al.
Publicado: (2022)

Structure‐Based Design, Synthesis, and Biological Evaluation of Triazole‐Based smHDAC8 Inhibitors
por: Kalinin, Dmitrii V., et al.
Publicado: (2020)

TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization
por: Bell, Jessica L., et al.
Publicado: (2013)

Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents †
por: D’Andrea, Felicia, et al.
Publicado: (2019)

Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors
por: Wang, Suhua, et al.
Publicado: (2022)

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
por: Ibrahim, Tarek S., et al.
Publicado: (2021)

2-Bromo-5,7-dimethoxy-4-phenylquinoline
por: Gopal, Veshal, et al.
Publicado: (2009)

Natural Product Rottlerin Derivatives Targeting Quorum Sensing
por: Suresh, Dittu, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold
por: Gao, Yuan, et al.
Publicado: (2023)

Synthesis of HDAC Substrate Peptidomimetic Inhibitors Using Fmoc Amino Acids Incorporating Zinc-Binding Groups
por: Mahindra, Amit, et al.
Publicado: (2019)

The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities()
por: Pasa, Salih, et al.
Publicado: (2016)

Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors
por: Al-Warhi, Tarfah, et al.
Publicado: (2020)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

Novel Phthalic-Based Anticancer Tyrosine Kinase Inhibitors: Design, Synthesis and Biological Activity
por: Kalinichenko, Elena, et al.
Publicado: (2023)

Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
por: Schäker‐Hübner, Linda, et al.
Publicado: (2022)

Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors
por: Kandakatla, Naresh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nli424k9u1uqtst79e0vchu4lm